Skip to content
Catalyst

esomeprazolePapers

Papers about esomeprazole

papers
199
27 years, by papers

Newest first

151 to 199 of 199

Every paper here, unless its row says otherwiseIndexed under esomeprazole in PubMed's chemical list

  • A multicenter, randomized, double-blind, 8-week comparative trial of standard doses of esomeprazole (40 mg) and omeprazole (20 mg) for the treatment of erosive esophagitis.

    Digestive diseases and sciences2006PMID 16642422

  • Maintenance of healed erosive esophagitis: a randomized six-month comparison of esomeprazole twenty milligrams with lansoprazole fifteen milligrams.

    Clinical gastroenterology and hepatology2006PMID 16682260

  • A multicenter, randomized, double-blind, 8-week comparative trial of low-dose esomeprazole (20 mg) and standard-dose omeprazole (20 mg) in patients with erosive esophagitis.

    Digestive diseases and sciences2006PMID 16773434

  • Esomeprazole with aspirin versus clopidogrel for prevention of recurrent gastrointestinal ulcer complications.

    Clinical gastroenterology and hepatology2006PMID 16797240

  • Randomized trial of rifabutin-based triple therapy and high-dose dual therapy for rescue treatment of Helicobacter pylori resistant to both metronidazole and clarithromycin.

    Alimentary pharmacology & therapeutics2006PMID 16842467

  • Intragastric acidity after switching from 5-day treatment with intravenous pantoprazole 40 mg/d to 5-day treatment with oral esomeprazole 40 mg/d or pantoprazole 40 mg/d: an open-label crossover study in healthy adult volunteers.

    Clinical therapeutics2006PMID 16861094

  • Sequential therapy using high-dose esomeprazole-amoxicillin followed by gatifloxacin for Helicobacter pylori infection.

    Alimentary pharmacology & therapeutics2006PMID 16918889

  • Clinical impact of CYP2C19 polymorphism on the action of proton pump inhibitors: a review of a special problem.

    International journal of clinical pharmacology and therapeutics2006PMID 16961157

  • Esomeprazole versus pantoprazole for healing erosive oesophagitis.

    Collegium antropologicum2006PMID 17058517

  • Comparative study of modified-release clarithromycin and immediate-release clarithromycin in the treatment of Helicobacter pylori-associated peptic ulcer disease.

    Hepato-gastroenterology2006PMID 17086891

  • Pharmacokinetic properties of esomeprazole in children aged 1 to 11 years with symptoms of gastroesophageal reflux disease: a randomized, open-label study.

    Clinical therapeutics2006PMID 17213007Also returned by a PubMed search for esomeprazole

  • Pantoprazole 40 mg is as effective as esomeprazole 40 mg to relieve symptoms of gastroesophageal reflux disease after 4 weeks of treatment and superior regarding the prevention of symptomatic relapse.

    Digestion2006PMID 17230024

  • A pharmacokinetic study comparing single and repeated oral doses of 20 mg and 40 mg omeprazole and its two optical isomers, S-omeprazole (esomeprazole) and R-omeprazole, in healthy subjects.

    European journal of clinical pharmacology2005PMID 15578172

  • Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding.

    The New England journal of medicine2005PMID 15659723

  • Efficacy of esomeprazole 40 mg vs. lansoprazole 30 mg for healing moderate to severe erosive oesophagitis.

    Alimentary pharmacology & therapeutics2005PMID 15709997

  • A randomized comparative study of esomeprazole 40 mg versus pantoprazole 40 mg for healing erosive oesophagitis: the EXPO study.

    Alimentary pharmacology & therapeutics2005PMID 15771760

  • Intragastric acidity during treatment with esomeprazole 40 mg twice daily or pantoprazole 40 mg twice daily--a randomized, two-way crossover study.

    Alimentary pharmacology & therapeutics2005PMID 15813831

  • Novel measurement of rapid treatment success with ReQuest: first and sustained symptom relief as outcome parameters in patients with endoscopy-negative GERD receiving 20 mg pantoprazole or 20 mg esomeprazole.

    Digestion2005PMID 15870503

  • Esomeprazole tablet vs omeprazole capsule in treating erosive esophagitis.

    World journal of gastroenterology2005PMID 15918199

  • A randomised prospective study comparing the effectiveness of esomeprazole treatment strategies in clinical practice for 6 months in the management of patients with symptoms of gastroesophageal reflux disease.

    International journal of clinical practice2005PMID 15924594Also returned by a PubMed search for esomeprazole

  • One-week once-daily triple therapy with esomeprazole, levofloxacin and azithromycin compared to a standard therapy for Helicobacter pylori eradication.

    Digestive and liver disease2005PMID 15996628

  • A comparison of esomeprazole and lansoprazole for control of intragastric pH in patients with symptoms of gastro-oesophageal reflux disease.

    Alimentary pharmacology & therapeutics2005PMID 16011671

  • Esomeprazole 20 mg vs. pantoprazole 20 mg for maintenance therapy of healed erosive oesophagitis: results from the EXPO study.

    Alimentary pharmacology & therapeutics2005PMID 16225489

  • A prospective randomized trial of esomeprazole- versus pantoprazole-based triple therapy for Helicobacter pylori eradication.

    The American journal of gastroenterology2005PMID 16279889

  • 40 mg pantoprazole and 40 mg esomeprazole are equivalent in the healing of esophageal lesions and relief from gastroesophageal reflux disease-related symptoms.

    Journal of clinical gastroenterology2004PMID 15087692

  • Effect of proton pump inhibitors and antacid therapy on 13C urea breath tests and stool test for Helicobacter pylori infection.

    The American journal of gastroenterology2004PMID 15128344

  • Esomeprazole versus omeprazole for the eradication of Helicobacter pylori infection: results of a randomized controlled study.

    Journal of clinical gastroenterology2004PMID 15220685

  • Masking of 13C urea breath test by proton pump inhibitors is dependent on type of medication: comparison between omeprazole, pantoprazole, lansoprazole and esomeprazole.

    Alimentary pharmacology & therapeutics2004PMID 15225178

  • The role of acid suppression in patients with endoscopy-negative reflux disease: the effect of treatment with esomeprazole or omeprazole.

    Alimentary pharmacology & therapeutics2004PMID 15298635

  • Esomeprazole 40 mg provides more effective intragastric acid control than lansoprazole 30 mg, omeprazole 20 mg, pantoprazole 40 mg and rabeprazole 20 mg in patients with gastro-oesophageal reflux symptoms.

    European journal of clinical pharmacology2004PMID 15349707

  • Esomeprazole 20 mg on-demand is more acceptable to patients than continuous lansoprazole 15 mg in the long-term maintenance of endoscopy-negative gastro-oesophageal reflux patients: the COMMAND Study.

    Alimentary pharmacology & therapeutics2004PMID 15352914

  • Esomeprazole 40 mg i.v. provides faster and more effective intragastric acid control than pantoprazole 40 mg i.v.: results of a randomized study.

    Alimentary pharmacology & therapeutics2004PMID 15569112

  • Pantoprazole: an update of its pharmacological properties and therapeutic use in the management of acid-related disorders.

    Drugs2003PMID 12487624

  • Esomeprazole 20 mg and lansoprazole 15 mg in maintaining healed reflux oesophagitis: Metropole study results.

    Alimentary pharmacology & therapeutics2003PMID 12562445

  • Review article: esomeprazole, 40 mg once daily, compared with lansoprazole, 30 mg once daily, in healing and symptom resolution of erosive oesophagitis.

    Alimentary pharmacology & therapeutics2003PMID 12614303

  • Esomeprazole 20 mg and lansoprazole 15 mg in maintaining healed reflux oesophagitis: Metropole study results.

    Alimentary pharmacology & therapeutics2003PMID 12614304

  • One-week triple therapy with esomeprazole, clarithromycin and metronidazole provides effective eradication of Helicobacter pylori infection.

    Alimentary pharmacology & therapeutics2003PMID 12786632

  • Intra-oesophageal pH profiles and pharmacokinetics of pantoprazole and esomeprazole: a crossover study in patients with gastro-oesophageal reflux disease.

    European journal of gastroenterology & hepatology2003PMID 12811310

  • Once-daily pantoprazole 40 mg and esomeprazole 40 mg have equivalent overall efficacy in relieving GERD-related symptoms.

    Alimentary pharmacology & therapeutics2003PMID 12969085

  • Oral esomeprazole vs. intravenous pantoprazole: a comparison of the effect on intragastric pH in healthy subjects.

    Alimentary pharmacology & therapeutics2003PMID 14510744

  • Esomeprazole-based one-week triple therapy with clarithromycin and metronidazole is effective in eradicating Helicobacter pylori in the absence of antimicrobial resistance.

    Alimentary pharmacology & therapeutics2003PMID 14535873

  • On-demand therapy for Los Angeles grade A and B reflux esophagitis: esomeprazole versus omeprazole.

    Journal of the Formosan Medical Association2003PMID 14625604

  • Gastric acid control with esomeprazole, lansoprazole, omeprazole, pantoprazole, and rabeprazole: a five-way crossover study.

    The American journal of gastroenterology2003PMID 14687806

  • Esomeprazole 40 mg provides improved intragastric acid control as compared with lansoprazole 30 mg and rabeprazole 20 mg in healthy volunteers.

    Digestion2003PMID 14691345

  • Esomeprazole (40 mg) compared with lansoprazole (30 mg) in the treatment of erosive esophagitis.

    The American journal of gastroenterology2002PMID 11922549

  • Effect of esomeprazole 40 mg vs omeprazole 40 mg on 24-hour intragastric pH in patients with symptoms of gastroesophageal reflux disease.

    Digestive diseases and sciences2002PMID 12018920

  • Efficacy and safety of esomeprazole compared with omeprazole in GERD patients with erosive esophagitis: a randomized controlled trial.

    The American journal of gastroenterology2001PMID 11280530

  • Esomeprazole provides improved acid control vs. omeprazole In patients with symptoms of gastro-oesophageal reflux disease.

    Alimentary pharmacology & therapeutics2000PMID 10886041

  • Esomeprazole improves healing and symptom resolution as compared with omeprazole in reflux oesophagitis patients: a randomized controlled trial. The Esomeprazole Study Investigators.

    Alimentary pharmacology & therapeutics2000PMID 11012468

← Previous 50